NRI

Aarti Drugs Ltd

Sector Pharmaceuticals
BSE 524348
NSE AARTIDRUGS
393.95
-11.10 (-2.74 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

389.30

Day High

405.05

52 Week Low

387.00

52 Week High

635.00

All Time Low

31.60

All Time High

3,447.05

Open

405.00

Close

405.05

Volume

75,647

Mkt cap (Cr)

3,595.58

P/E ratio

24.37

P/B ratio

0.34%

Div yield

0.25%

6M return

-23.52%

1Y return

-24.98%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

393.95 -2.74%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Aarti Drugs Ltd

Stock PE (TTM)

24.37

Promoter Holding

55.38%

Book Value

139.0183

ROCE

14.97%

ROE

13.87%

Aarti Drugs Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 5,768.98 crores, it is incorporated in the year 1984. It features consolidated sales of Rs. 579.95 crores in June 2021. It is also listed in the Bombay Stock Exchange (BSE) with the code 524348 and listed in the National Stock Exchange (NSE) with the code AARTIDRUGS.

Aarti Drugs Ltd was incorporated as a private limited company on 28th September ’1984 and converted into a public limited company in 1992. It is owned by Aarti Industries Ltd, which also owns a Research & Development plant in Tarapur, Maharashtra. The Company is engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. The Company operates through eight manufacturing facilities, two of which are strategically located in the state of Gujarat and Maharashtra. Also, all the manufacturing units of Aarti Industries are GMP certified, and therefore, the Company is additionally in the process of acquiring certification as per ISO 9002 compliance standard for all its units, out of which one has received the certification. The promoters of the Company currently hold 60.14% of the stake in the Company, while the Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) hold 2.57% and 2% of the stake. The balance of 35.29% is held by others (retail investors).

In June 2021, quarterly net sales were Rs. 505.79 crores, which has increased by approximately 6.36% from Rs. 475.55 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 45.54 crores, which has fallen by 37.64% from a net profit of Rs. 73.03 crores in June 2020. In June 2021, the operating profit was Rs. 429.79 crores, which is also increased by 3.51% as compared to the operating profit of Rs. 415.22 crores for the quarter ending in June 2020. From Rs. 31.34 in June 2020, the EPS of Aarti Drugs has been reduced to just Rs. 4.9 per share in June 2021. AARTIDRUGS’s stock closed at Rs. 634.80 on 16th August’2021 (NSE) and has returned -1.50% in the last six months and -70.23% in the last year.

Aarti Drugs share price as on 11 Feb 2025 is Rs. 393.95. Over the past 6 months, the Aarti Drugs share price has decreased by 23.52% and in the last one year, it has decreased by 24.98%. The 52-week low for Aarti Drugs share price was Rs. 387 and 52-week high was Rs. 635.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

524348

AARTIDRUGS

INE767A01016

Sep

Aarti Drugs Ltd FAQs

You can buy Aarti Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarti Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 11, 2025 03:58 PM the closing price of Aarti Drugs Ltd was Rs.393.95.

The latest PE ratio of Aarti Drugs Ltd as of Feb 11, 2025 03:58 PM is 24.37

The latest PB ratio of Aarti Drugs Ltd as of Feb 11, 2025 03:58 PM is 0.34

The 52-week high of Aarti Drugs Ltd share price is Rs. 635.00 while the 52-week low is Rs. 387.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 11, 2025 03:58 PM, the market cap of Aarti Drugs Ltd stood at Rs. 3,595.58 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.